Search Results Search Sort by RelevanceMost Recent Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured. Medicine and Society May 2024 How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers? Majd Alsoubani, MD, Maya L. Nadimpalli, PhD, MS, and Shira Doron, MD Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably. AMA J Ethics. 2024;26(5):E383-389. doi: 10.1001/amajethics.2024.383. Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4
Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.
Medicine and Society May 2024 How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers? Majd Alsoubani, MD, Maya L. Nadimpalli, PhD, MS, and Shira Doron, MD Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably. AMA J Ethics. 2024;26(5):E383-389. doi: 10.1001/amajethics.2024.383.
Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.